{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:21:17Z","timestamp":1792092077296,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ogc.2011.02.016","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T22:52:31Z","timestamp":1306018351000},"page":"271-295","source":"Crossref","is-referenced-by-count":19,"title":["Acquired and Inherited Thrombophilia Disorders in Pregnancy"],"prefix":"10.1016","volume":"38","author":[{"given":"Silvia S.","family":"Pierangeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Leader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Barilaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ware","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2011.02.016_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/26.5.324","article-title":"Syndrome of the black swan","volume":"26","author":"Harris","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib3","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMcp1005330","article-title":"Clinical practice. Recurrent miscarriage","volume":"363","author":"Branch","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2011.02.016_bib4","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/oxfordjournals.humrep.a136224","article-title":"Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach","volume":"10","author":"Rai","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2011.02.016_bib5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0015-0282(16)58565-3","article-title":"Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies","volume":"66","author":"Yetman","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2011.02.016_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/0961203310361490","article-title":"Obstetric antiphospholipid syndrome: current uncertainties should guide our way","volume":"19","author":"Branch","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203310395054","article-title":"Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies","volume":"20","author":"Branch","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.AOG.0000248537.89739.96","article-title":"Fetal death","volume":"109","author":"Silver","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib11","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.292.18.2249","article-title":"First-trimester placentation and the risk of antepartum stillbirth","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2011.02.016_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0029-7844(95)00498-X","article-title":"Antiphospholipid antibodies and fetal death","volume":"87","author":"Oshiro","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0002-9378(98)70439-9","article-title":"The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development","volume":"178","author":"Meis","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11926-007-0035-9","article-title":"Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?","volume":"9","author":"Clark","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ogc.2011.02.016_bib15","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0b013e3181fe02ec","article-title":"Association of anticardiolipin antibodies with preeclampsia. A systematic review and meta-analysis","volume":"116","author":"do Prado","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0002-9378(16)32527-3","article-title":"Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant","volume":"142","author":"De Wolf","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/art.1780310307","article-title":"Lupus pregnancy. A prospective study of placental changes","volume":"31","author":"Hanly","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ogc.2011.02.016_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0046-8177(96)90377-9","article-title":"Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of the literature","volume":"27","author":"Nayar","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ogc.2011.02.016_bib19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0002-9378(93)90408-B","article-title":"The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production","volume":"169","author":"Peaceman","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.placenta.2003.12.006","article-title":"Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes","volume":"25","author":"Van Horn","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.ogc.2011.02.016_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/hh0102.102795","article-title":"Molecular pathogenesis of the antiphospholipid syndrome","volume":"11","author":"Rand","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.ogc.2011.02.016_bib22","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/0002-9378(94)90403-0","article-title":"Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion","volume":"171","author":"Rand","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0961203310361485","article-title":"The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis","volume":"19","author":"Rand","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0028-2243(91)90021-C","article-title":"Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies","volume":"41","author":"Out","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ogc.2011.02.016_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1196\/annals.1422.054","article-title":"Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature","volume":"1108","author":"Di Simone","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ogc.2011.02.016_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/humrep\/17.4.1067","article-title":"Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure","volume":"17","author":"Sebire","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2011.02.016_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","article-title":"Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I","volume":"43","author":"Di Simone","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ogc.2011.02.016_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1095\/biolreprod56.1.50","article-title":"Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion","volume":"56","author":"Katsuragawa","year":"1997","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ogc.2011.02.016_bib29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1095\/biolreprod53.4.905","article-title":"Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR","volume":"53","author":"Adler","year":"1995","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ogc.2011.02.016_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0897.1998.tb00344.x","article-title":"The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome","volume":"39","author":"Rote","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ogc.2011.02.016_bib31","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.27361","article-title":"Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation","volume":"62","author":"Di Simone","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ogc.2011.02.016_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1191\/0961203303lu405oa","article-title":"The effects of antiphospholipid antibodies obtained from women with SLE\/APS and associated pregnancy loss on rat embryos and placental explants in culture","volume":"12","author":"Ornoy","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.8755-8920.2003.00140.x","article-title":"Antiphosphatidylserine antibodies affect rat yolk sacs in culture: a mechanism for fetal loss in antiphospholipid syndrome","volume":"51","author":"Matalon","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ogc.2011.02.016_bib34","first-page":"35","article-title":"Effects of a toll-like receptor antagonist and anti-annexin A2 antibodies on binding and activation of decidual cells by anti-\u03b22glycoprotein I antibodies","volume":"2","author":"Borghi","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/molehr\/gal048","article-title":"Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome","volume":"12","author":"Francis","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ogc.2011.02.016_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1095\/biolreprod.110.083410","article-title":"Antiphospholipid antibodies affect human endometrial angiogenesis","volume":"83","author":"Di Simone","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ogc.2011.02.016_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ogc.2011.02.016_bib38","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1073\/pnas.0607514104","article-title":"Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6","volume":"104","author":"Martinez de la Torre","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ogc.2011.02.016_bib39","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.160.9.4553","article-title":"Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor","volume":"160","author":"Quigg","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ogc.2011.02.016_bib40","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ogc.2011.02.016_bib41","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","article-title":"Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury","volume":"110","author":"Redecha","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ogc.2011.02.016_bib42","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ogc.2011.02.016_bib43","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ogc.2011.02.016_bib44","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ogc.2011.02.016_bib45","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.ajog.2006.10.879","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2007.02.013","article-title":"Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?","volume":"28","author":"Cavazzana","year":"2007","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.ogc.2011.02.016_bib47","first-page":"99","article-title":"Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation","volume":"118","author":"Salmon","year":"2007","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.ogc.2011.02.016_bib48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib49","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection","volume":"10","author":"Pengo","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib50","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nprot.2008.48","article-title":"A\u00a0protocol for determination of anticardiolipin antibodies by ELISA","volume":"3","author":"Pierangeli","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ogc.2011.02.016_bib51","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ogc.2011.02.016_bib52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib53","first-page":"215","article-title":"Evaluation of the anticardiolipin antibody test: report of an international workshop held April 4 1986","volume":"68","author":"Harris","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ogc.2011.02.016_bib54","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajcp\/101.5.616","article-title":"The Second International Anticardiolipin Standardization Workshop: the Kingston Anticardiolipin Antibody Study (KAPS) group","volume":"101","author":"Harris","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ogc.2011.02.016_bib55","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajcp\/101.5.616","article-title":"Anticardiolipin wet workshop report: Vth international symposium on antiphospholipid antibodies","volume":"101","author":"Harris","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ogc.2011.02.016_bib56","first-page":"156","article-title":"Report of an anticardiolipin workshop during the VIIth International Symposium on antiphospholipid antibodies","volume":"25","author":"Pierangeli","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib57","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0038-1653795","article-title":"Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies","volume":"73","author":"Reber","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/00313020410001672046","article-title":"Anticardiolipin antibody testing and reporting practices among laboratories participating in a large external quality assurance program","volume":"36","author":"Wong","year":"2004","journal-title":"Pathology"},{"key":"10.1016\/j.ogc.2011.02.016_bib59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1616089","article-title":"Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations\u2013a cooperative project of the European Antiphospholipid Forum","volume":"86","author":"Tincani","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0961203310397082","article-title":"\u201cNon-criteria\u201d aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010","volume":"20","author":"Bertolaccini","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/ajcp\/106.4.549","article-title":"Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies","volume":"106","author":"Laroche","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ogc.2011.02.016_bib62","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/rheumatology\/37.11.1229","article-title":"Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome","volume":"37","author":"Bertolaccini","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.33549\/physiolres.930000.49.299","article-title":"Prevalence of various antiphospholipid antibodies in pregnant women","volume":"49","author":"Fialova","year":"2000","journal-title":"Physiol Res"},{"key":"10.1016\/j.ogc.2011.02.016_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0198-8859(02)00789-9","article-title":"Antibodies to anionic phospholipids and anti-\u03b22GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus","volume":"64","author":"Amoroso","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ogc.2011.02.016_bib65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1309\/6MPULFBL24FM9B50","article-title":"Diagnostic performance of phospholipid-specific assays for the evaluation of antiphospholipid syndrome","volume":"129","author":"Tebo","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ogc.2011.02.016_bib66","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2249.2008.03774.x","article-title":"Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss","volume":"154","author":"Tebo","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ogc.2011.02.016_bib67","first-page":"27","article-title":"Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions","volume":"39","author":"Matzner","year":"1994","journal-title":"J\u00a0Reprod Med"},{"key":"10.1016\/j.ogc.2011.02.016_bib68","first-page":"83","article-title":"Patterns of anti-phospholipid antibody specificities","volume":"35","author":"Gilman-Sachs","year":"1991","journal-title":"J\u00a0Clin Lab Immunol"},{"key":"10.1016\/j.ogc.2011.02.016_bib69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1653808","article-title":"Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation","volume":"73","author":"Campbell","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib70","first-page":"591","article-title":"Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with a variety of connective tissue diseases","volume":"26","author":"Merkel","year":"1999","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0197-1859(95)80012-3","article-title":"A\u00a0more specific ELISA assay for the detection of antiphospholipid antibodies","volume":"15","author":"Harris","year":"1995","journal-title":"Clin Immunol Newslett"},{"key":"10.1016\/j.ogc.2011.02.016_bib72","first-page":"667","article-title":"Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests","volume":"25","author":"Day","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib73","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0029-7844(02)02520-6","article-title":"Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro","volume":"101","author":"Franklin","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib74","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/17.11.2981","article-title":"Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population","volume":"17","author":"Franklin","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ogc.2011.02.016_bib75","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0029-7844(97)00065-3","article-title":"Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome","volume":"89","author":"Branch","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00000441-199907000-00009","article-title":"IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus","volume":"318","author":"Cucurull","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ogc.2011.02.016_bib77","first-page":"C156","article-title":"Antiphospholipid antibodies and recurrent pregnancy loss: prevalence of anticardiolipin antibodies, the lupus anticoagulant, and antiphosphatidyl serine antibodies","volume":"19","author":"Kutteh","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib78","first-page":"1104","article-title":"Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus","volume":"25","author":"Bertolaccini","year":"1998","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib79","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2141.2001.02716.x","article-title":"Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome","volume":"113","author":"Donohoe","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ogc.2011.02.016_bib80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0038-1650296","article-title":"Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men","volume":"75","author":"Vaarala","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib81","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1055\/s-0038-1650686","article-title":"Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies","volume":"76","author":"Horbach","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0038-1655994","article-title":"Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies","volume":"77","author":"Galli","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib83","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/s-0038-1657678","article-title":"Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies","volume":"78","author":"Forastiero","year":"1997","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ogc.2011.02.016_bib84","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1055\/s-0038-1649940","article-title":"Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome","volume":"74","author":"Pierangeli","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ajcp\/98.4.449","article-title":"Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion","volume":"98","author":"Lopez","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ogc.2011.02.016_bib86","first-page":"291","article-title":"Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus","volume":"24","author":"Molina","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib87","first-page":"1187","article-title":"Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus","volume":"18","author":"Wong","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib88","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(88)80229-8","article-title":"Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus","volume":"85","author":"Kalunian","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ogc.2011.02.016_bib89","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0037-1614978","article-title":"IgA anticardiolipin antibodies\u2013relation with other antiphospholipid antibodies and clinical significance","volume":"79","author":"Selva-O'Callaghan","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ogc.2011.02.016_bib90","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients","volume":"68","author":"Alarcon-Segovia","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ogc.2011.02.016_bib91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/096120330000900110","article-title":"Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus","volume":"9","author":"Spadaro","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib92","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1191\/096120399678847812","article-title":"Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype","volume":"8","author":"Diri","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib93","first-page":"2637","article-title":"The value of IgA antiphospholipid testing for the diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus","volume":"28","author":"Bertolaccini","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib94","first-page":"1775","article-title":"Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"33","author":"Danowski","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ogc.2011.02.016_bib95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0961203309360541","article-title":"Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort","volume":"19","author":"Petri","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib96","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/1529-0131(199912)42:12<2727::AID-ANR33>3.0.CO;2-Q","article-title":"IgA-class anti-beta2-glycoprotein I in women with unexplained recurrent spontaneous abortion","volume":"42","author":"Yamada","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ogc.2011.02.016_bib97","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1067\/mob.2001.117659","article-title":"Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death","volume":"185","author":"Lee","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib98","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2249.1999.01007.x","article-title":"Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (\u03b22GPI) antibodies: importance of IgA isotype","volume":"117","author":"Lakos","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ogc.2011.02.016_bib99","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0029-7844(03)00477-0","article-title":"Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia","volume":"102","author":"Lee","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203309103048","article-title":"Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients","volume":"18","author":"Kumar","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.ogc.2011.02.016_bib101","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live birth in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.ogc.2011.02.016_bib102","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and metaanalysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib103","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MED.0b013e328332b81e","article-title":"Management of inherited thrombophilia in pregnancy","volume":"16","author":"Fogerty","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ogc.2011.02.016_bib104","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.2010.05674.x","article-title":"Coagulation disorders in pregnancy: acquired and inherited thrombophilias","volume":"1205","author":"Benedetto","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ogc.2011.02.016_bib105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/GRF.0b013e3181eb658c","article-title":"Thrombophilias and stillbirth","volume":"53","author":"Werner","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ogc.2011.02.016_bib106","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ogc.2011.02.016_bib107","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.AOG.0000173986.32528.ca","article-title":"The relationship of the Factor V Leiden mutation in pregnancy outcomes for mother and fetus","volume":"106","author":"Dizon-Townson","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2011.02.016_bib108","doi-asserted-by":"crossref","first-page":"e1000292","DOI":"10.1371\/journal.pmed.1000292","article-title":"The association of factor V Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies","volume":"7","author":"Rodger","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.ogc.2011.02.016_bib109","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage","volume":"115","author":"Clark","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ogc.2011.02.016_bib110","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854511000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854511000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T19:06:01Z","timestamp":1741201561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854511000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0889854511000295"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2011.02.016","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}